Vertex Signs US$1.6 B Gene Therapy Vector Partnership with Affinia
By Michelle Liu
Pharma Deals Review: Vol 2020 Issue 5 (Table of Contents)
Published: 8 May-2020
DOI: 10.3833/pdr.v2020.i5.2535 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Continuing to invest in its gene therapy capabilities, Vertex Pharmaceuticals has agreed to partner with Affinia Therapeutics in a deal worth up to US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS